PolyPid Ltd. Ordinary Shares (PYPD) Dividend History

Company News

• PolyPid to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

  PolyPid, a late-stage biopharma company, announced that it will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11-12, 2025. The company's lead product candidate, D-PLEX100, is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections.

  GlobeNewswire Inc.
• PolyPid to Report Fourth Quarter and Full-Year 2024 Financial Results and Operational Highlights on February 12, 2025

  PolyPid, a late-stage biopharma company, will report its Q4 and full-year 2024 financial results and operational highlights on February 12, 2025. The company will host a conference call to discuss the results and provide an update on business operations.

  GlobeNewswire Inc.
• PolyPid Announces Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 Patients with a Concurrent Private Placement of up to $41 Million

  PolyPid announced a positive recommendation from the DSMB to continue enrollment of its Phase 3 SHIELD II trial for D-PLEX100, a drug candidate for preventing surgical site infections. The company also announced a $41 million private placement financing to support the trial and potential future regulatory submissions.

  GlobeNewswire Inc.
• PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

  PolyPid, a late-stage biopharma company, has received a notification from Nasdaq regarding its failure to maintain the minimum stockholders' equity requirement for continued listing. The company has 45 days to submit a plan to regain compliance, and expects to do so if warrants from recent private placements are exercised.

  GlobeNewswire Inc.
• PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024

  PolyPid, a late-stage biopharma company, will report its third quarter 2024 financial results and operational highlights on November 13, 2024. The company will host a conference call and webcast to discuss the results and provide an update on business operations.

  GlobeNewswire Inc.